Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1952;5:20-27

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FREIS, E. D.
Right arrow Articles by JOHNSON, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FREIS, E. D.
Right arrow Articles by JOHNSON, R. L.

(Circulation. 1952;5:20.)
© 1952 American Heart Association, Inc.


The Treatment of Hypertension with Hexamethonium

EDWARD D. FREIS M.D.1; FRANK A. FINNERTY JR. M.D.1; HAROLD W. SCHNAPER M.D.1; ROBERT L. JOHNSON M.C., U. S. A. F.1

1 From The Cardiovascular Research Laboratory, Georgetown University Hospital and the Department of Medicine, Georgetown University School of Medicine, the Georgetown Medical Division, Gallinger Municipal Hospital, and the Veterans Administration Hospital, Washington, D. C.

Hexamethonium by subcutaneous injection in doses of 10 to 75 mg. of the ion every 8 or 12 hours produced significant reductions of arterial pressure and symptomatic improvement in a high percentage of patients with benign or malignant hypertension. Methods for preventing tolerance and undesirable side effects are presented, and the advantages as well as the limitations of hexamethonium therapy are discussed.




This article has been cited by other articles:


Home page
ANGIOLOGYHome page
M. A. Lindauer and J. H. Hafken Schiel
Hexamethonium Chloride With Reserpine in the Treatment of Severe Essential Hypertension
Angiology, February 1, 1958; 9(1): 19 - 23.
[PDF]


Home page
Arch Intern MedHome page
E. D. FREIS and I. M. WILSON
Mecamylamine, a New, Orally Effective, Experimental and Clinical Evaluation
Arch Intern Med, May 1, 1956; 97(5): 551 - 561.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
W. M. KIRKENDALL and J. W. CULBERTSON
MANAGEMENT OF SYSTEMIC ARTERIAL HYPERTENSION
Arch Intern Med, April 1, 1955; 95(4): 601 - 613.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
R. S. SCHAAF
CARDIOVASCULAR DISEASES: A Review of Some Significant Publications (July 1949-June 1952)
Arch Intern Med, March 1, 1954; 93(3): 407 - 463.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
T. D. ULLMANN and D. DIENGOTT
EFFECT OF HEXAMETHONIUM (C6) ON RENAL HEMODYNAMICS IN MAN
Arch Intern Med, August 1, 1953; 92(2): 228 - 237.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
P. H. Kuhn
The Use of Oral Hexamethonium Chloride (Methium in the Treatment of Hypertension
Angiology, June 1, 1953; 4(3): 195 - 206.
[PDF]


Home page
Arch Intern MedHome page
H. A. SCHROEDER
CONTROL OF HYPERTENSION BY HEXAMETHONIUM AND 1-HYDRAZINOPHTHALAZINE: Preliminary Observations
Arch Intern Med, April 1, 1952; 89(4): 523 - 540.
[Abstract] [PDF]